Perioperative thrombotic complications associated with pediatric liver transplantation: a UNOS database evaluation

Dmitri Bezinover1, Molly F Deacutis1, Priti G Dalal1

  • 1Departments of Anesthesiology and Perioperative Medicine, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, USA.

Insights

Pediatric liver transplant patients, especially those under 5, face higher risks of portal vein thromboses (PVT) and graft failure. Preoperative PVT increases the likelihood of postoperative complications, suggesting a need for antithrombotic therapy.

Area of Science:

  • Hepatology
  • Pediatric Surgery
  • Transplantation Medicine

Background:

  • Portal vein thrombosis (PVT) is a significant concern in pediatric liver transplantation (LT).
  • Understanding the prevalence and risk factors for pre- and postoperative thromboses is crucial for improving outcomes.

Purpose of the Study:

  • To evaluate the prevalence of preoperative PVT and postoperative thromboses in pediatric LT recipients.
  • To identify factors associated with these thrombotic events and graft failure.

Main Methods:

  • Retrospective analysis of the UNOS database for pediatric LT cases between 2000 and 2015.
  • Patients were stratified into three age groups: 0-5, 6-11, and 12-18 years.
  • Statistical analysis to determine factors predictive of thromboses.

Main Results:

  • Out of 8982 pediatric LT, 4.3% had preoperative PVT and 4.4% had postoperative thromboses.
  • Younger age groups (0-5 and 6-11 years) showed a higher prevalence of both types of thromboses compared to older children (12-18 years).
  • Preoperative PVT independently predicted postoperative thromboses (OR=1.7), and younger children (<5 years) had increased odds of postoperative thromboses leading to graft failure (OR=2.9).

Conclusions:

  • Younger pediatric liver transplant recipients are more susceptible to thrombotic complications.
  • Preoperative PVT is a significant risk factor for postoperative thromboses.
  • Consideration of perioperative antithrombotic therapy is recommended for pediatric LT patients.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
844
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
873
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.3K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311